By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Insider activity at Resmed Inc has been all selling for a year now: about $22.3 million from five sellers, and zero buyers at market prices.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters. 885 investment managers listed RMD in their latest 13F filings (Q2 2026); more funds sold than bought. RMD also shows up in congressional disclosures: 8 reported trades from four lawmakers in two years.
Are insiders buying or selling RMD stock?
In the last 12 months Resmed Inc insiders made open-market purchases worth about $0 and sales worth about $22.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in RMD?
The most recent open-market insider trade in RMD was filed on 2026-10-08.
How many institutions own RMD?
885 investment managers reported holding RMD in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded RMD?
Yes. Members of Congress reported 8 trades in RMD over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).